1. A New Era of Renal Denervation Trials for Patients With Hypertension?
Fatima Jalil, William B. White 
American Journal of Kidney Diseases 
Volume 71, Issue 5, Pages (May 2018)
DOI: /j.ajkd
Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions

2. Figure 1
Summary of goals and pathways to address the goals for the development of device therapies in hypertension. ∗BDNF, brain-derived neurotrophic factor. ∗∗Phase 2 study could be performed before phase 3 or nested within the phase 3 trial. Abbreviation: BP, blood pressure.
Reproduced from White et al5 with permission of Elsevier.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions